Therefore, to extend the relationship between the SGLT2 inhibitor and IR, we further examined the effect of 12 wks of DAPA treatment on circulating ZAG levels in T2DM subjects. The gene discussed is SLC5A2; the disease is type 2 diabetes mellitus.